证券代码：000809 证券简称：和展能源 公告编号：2025-032 辽宁和展能源集团股份有限公司 关于为全资子公司提供担保的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完 整，没有虚假记载、误导性陈述或重大遗漏。 特别提示： 本次担保为公司对资产负债率超过 70%的全资子公司提供的担保，敬请投资 者关注担保风险。 一、担保情况概述 为满足业务发展需要，辽宁和展能源集团股份有限公司（以下简称"公司"） 二级全资子公司辽宁昌和风电设备有限公司（以下简称"昌和风电"）向上海浦 东发展银行股份有限公司铁岭分行（以下简称"浦发银行"）申请不超过人民币 8,000 万元授信。2025 年 6 月 30 日，公司与浦发银行签署《最高额保证合同》， 公司为昌和风电向浦发银行在 2025 年 6 月 25 日至 2026 年 6 月 24 日期间内办理 各类融资业务以本金余额最高不超过人民币 5,000 万元为限提供连带责任保证 担保，公司对债权发生期间内各单笔借款合同项下分期履行的还款义务承担保证 责任，保证期间为自每笔债权合同债务履行期届满之日起至该单笔合同最后一期 还款期限届满之日后三年。 2025 ...

[Current Period Performance Forecast](index=1&type=section&id=Item%201.%20Current%20Period%20Performance%20Forecast) The company forecasts a net loss for the first half of 2025, with a significant reduction in the loss amount compared to the prior year [Performance Forecast](index=1&type=section&id=Item%201.%20Current%20Period%20Performance%20Forecast) The company anticipates a net loss for H1 2025, with a significant reduction in the loss amount compared to the prior year, narrowing from **53.20 million yuan** to an estimated **30.50-39.50 million yuan** Performance Forecast Summary | Item | Current Period (Jan 1 - Jun 30, 2025) | Prior Period (Jan 1 - Jun 30, 2024) | | :--- | :--- | :--- | | **Net Profit Attributable to Shareholders of Listed Company** | Loss: 30.50 – 39.50 Million Yuan | Loss: 53.20 Million Yuan | | **Net Profit After Deducting Non-Recurring Gains and Losses** | Loss: 33.50 – 42.50 Million Yuan | Loss: 53.21 Million Yuan | | **Basic Earnings Per Share** | Loss: 0.037 – 0.048 Yuan/Share | Loss: 0.064 Yuan/Share | - The performance forecast indicates the company is in a loss-making state during the current reporting period[2](index=2&type=chunk) [Communication with Accounting Firm](index=1&type=section&id=Item%202.%20Communication%20with%20Accounting%20Firm) The company's performance forecast is a preliminary estimate and has not undergone pre-audit by a certified public accountant [Audit Status Explanation](index=1&type=section&id=Item%202.%20Communication%20with%20Accounting%20Firm) This performance forecast represents preliminary calculations by the company's finance department and has not been pre-audited by a certified public accountant - This performance forecast has not been pre-audited by a certified public accountant[3](index=3&type=chunk) [Explanation of Performance Changes](index=1&type=section&id=Item%203.%20Explanation%20of%20Performance%20Changes) The company's loss is attributed to delayed project deliveries and nascent new energy operations, while the reduced loss is due to asset divestiture and investment income [Loss Cause Analysis](index=1&type=section&id=Item%203.1%20Loss%20Causes) The current period's loss is primarily due to delayed production and delivery in the hybrid tower equipment business, preventing revenue recognition, and the nascent stage of the new energy business which has not yet generated income - Delayed delivery of hybrid tower products due to project location in the north and buyer model adjustments resulted in no sales revenue from hybrid tower equipment in the current period, only prestressed construction income; **25 sets were produced in H1**, with deliveries expected to commence in Q3[4](index=4&type=chunk) - The company's new energy business remains in the development, approval, and construction phases, thus generating no revenue[4](index=4&type=chunk) [Year-over-Year Loss Reduction Analysis](index=1&type=section&id=Item%203.2%20Loss%20Reduction%20Causes) Compared to the prior year, the company's loss decreased by **25.75% to 42.67%**, primarily due to the divestiture of underperforming land primary development business and investment income from idle funds - The company divested significant assets of its controlled subsidiary, Tieling Caijing Investment Co., Ltd., at the end of 2024, reducing its stake to **38.68%** and thereby eliminating losses from the land primary development business accounted for by the equity method[4](index=4&type=chunk) - The company generated investment income from idle funds, contributing to the reduction in losses[5](index=5&type=chunk) [Other Relevant Information](index=2&type=section&id=Item%204.%20Other%20Relevant%20Information) The company reiterates that the performance forecast is preliminary and advises investors to consult official disclosures and exercise caution [Risk Warning and Information Disclosure](index=2&type=section&id=Item%204.%20Other%20Relevant%20Information) The company emphasizes that this performance forecast is a preliminary estimate, with final detailed financial data to be disclosed in the 2025 semi-annual report, and advises investors to monitor designated media and be aware of investment risks - This performance forecast is a preliminary calculation by the company's finance department, with final financial data subject to the 2025 semi-annual report[6](index=6&type=chunk) - The company's designated information disclosure media include China Securities Journal, Shanghai Securities News, Securities Daily, Securities Times, and Juchao Information Network, cautioning investors about investment risks[6](index=6&type=chunk)

Group 1 - TaiLong Pharmaceutical plans to apply for the registration and issuance of super short-term financing bonds not exceeding 800 million yuan, with a maturity of no more than 270 days, for purposes including replacing bank loans and supplementing working capital [1] - GuoXin Technology won a bid for a 46 million yuan automotive airbag ignition driver chip project, indicating its growing presence in the automotive semiconductor market [1] - GuoMai Technology expects a net profit increase of 60.52% to 100.33% for the first half of 2025, with a projected net profit of 125 million to 156 million yuan [2] Group 2 - ChangAluminum's subsidiary signed a 165 million yuan contract for the customized construction of a clinical and industrial base for a vaccine project, highlighting its involvement in the biopharmaceutical sector [3] - ZhongSalt Chemical acquired exploration rights for natural soda ash in Inner Mongolia for 929,000 yuan, expanding its resource base [4] - Six Kingdom Chemical announced the resignation of its deputy general manager, which may impact its operational strategy [5][6] Group 3 - FuYuan Pharmaceutical received a drug registration certificate for Bisoprolol Amlodipine tablets, indicating its expansion in the hypertension treatment market [7][8] - GuanShi Technology's subsidiary received a government subsidy of 7 million yuan, which is 45.29% of its net profit for the previous year, enhancing its financial position [9] - XiZhong Technology plans to repurchase shares worth between 75 million and 150 million yuan, aimed at employee stock ownership plans or equity incentives [10] Group 4 - BeiLu Pharmaceutical's subsidiary received approval for the raw material drug Iopromide, which is used as a contrast agent for various imaging examinations [12] - HongHui New Materials obtained a patent for a water-based protective paint for hardware parts, enhancing its product portfolio [13] - BoJi Pharmaceutical's subsidiary received two patents related to high bioavailability formulations, indicating innovation in biopharmaceutical technology [14] Group 5 - ChengJian Development received a cash dividend of 23.625 million yuan from its investment in Huaneng Capital, contributing to its investment income [15] - JiuZhou Pharmaceutical's subsidiary received a drug registration certificate for Sildenafil Citrate orally disintegrating tablets, expanding its product offerings in the erectile dysfunction treatment market [16] - RuiAng Gene's subsidiary received a government subsidy of 176,290 yuan, supporting its operational activities [17] Group 6 - FengFan Technology plans to acquire 100% equity of a subsidiary for 48 million yuan, indicating strategic expansion in the renewable energy sector [18] - AoJing Medical's subsidiary received a medical device production license, allowing it to manufacture absorbable surgical dressings [19] - TaiLin Bio's subsidiary won land use rights for an industrial site, facilitating its high-performance filter project [20] Group 7 - KaiPu Bio received a patent for a method and device for analyzing genomic copy number variations, enhancing its capabilities in molecular diagnostics [21] - Shanghai KaiBao received a drug registration certificate for Phlegm-Heat Clearing Capsules, which can be used in the treatment of COVID-19 symptoms [23] - TuoJing Life received two patents for high uniformity streptavidin applications, improving its diagnostic product stability [25] Group 8 - AnKe Bio's AK2024 injection received approval for clinical trials, marking a significant advancement in cancer treatment [26] - HuanYuan Pharmaceutical expects a net profit of 142 million to 160 million yuan for the first half of 2025, reflecting substantial growth [27] - JinHongShun terminated a major asset restructuring plan due to a lack of consensus among parties involved, impacting its strategic direction [28] Group 9 - HeZhan Energy signed a 177 million yuan contract for the sale of steel-concrete tower structures, indicating strong demand in the renewable energy sector [29] - InSai Group's acquisition plan for an 80% stake in ZhiZheTongXing was accepted by the Shenzhen Stock Exchange, indicating growth in its consulting business [30] - JiuDian Pharmaceutical received a drug registration certificate for Zinc Granules, enhancing its product line in gastrointestinal treatments [32] Group 10 - GuoYao Modern plans to publicly transfer a 51% stake in its subsidiary to optimize resource allocation [34] - GuoYao Modern's subsidiary received a drug registration certificate for Perindopril Indapamide tablets, expanding its hypertension treatment portfolio [36] - ZhongGong International signed a 175 million yuan engineering consulting service contract, showcasing its capabilities in project management [38] Group 11 - China Railway won contracts worth approximately 5.343 billion yuan for overseas construction projects, indicating its strong international presence [39] - JunPu Intelligent signed a framework contract for humanoid robot sales worth about 28.25 million yuan, reflecting growth in the robotics sector [41] - Sinopec's chairman resigned due to age, which may lead to changes in corporate governance [42] Group 12 - JiuFeng Energy's controlling shareholder plans to reduce their stake by up to 0.71%, indicating potential changes in ownership structure [44] - Zhejiang Oriental's subsidiary plans to establish a 1.74 billion yuan equity investment fund, focusing on strategic emerging industries [46] - ChenGuang New Materials received a government subsidy of 26 million yuan, significantly impacting its financial performance [48]

Core Viewpoint - The successful signing of the mixed tower order reflects the client's recognition of the company's product reliability, economic efficiency, and customization capabilities, enhancing the company's market reputation in the wind power tower sector [1][2] Group 1: Contract Details - The contract signed between Changhe Company and Beijing Puhua Sunshine Investment Co., Ltd. involves the procurement of 54 sets of 160m steel-concrete towers for the Mudanjiang Linkou 300MW wind power project, with a total contract value of 177.12 million yuan (including tax) [1] - The delivery of the signed mixed tower order is expected to occur between October 2025 and December 2026, positively impacting the financial status and operational results for 2025 and 2026 [2] Group 2: Production and Supply Plans - Changhe Company will commence site construction, mold design, and production preparations immediately, with plans to complete material stocking by August 2025 and to fulfill 30 sets of production tasks by November 2025 [1][2] - The company aims to enhance its market expansion capabilities and industry competitiveness through this order, striving for better and faster development of its mixed tower business to improve revenue and profitability [2]

Overview - The company, Liaoning Hezhan Energy Group Co., Ltd., provides a guarantee for its wholly-owned subsidiary, Liaoning Changhe Wind Power Equipment Co., Ltd., to secure a loan from Shanghai Pudong Development Bank, with a maximum principal amount of RMB 50 million [1][2]. Guarantee Details - The guarantee is for a loan amount of RMB 9.0304 million, with a loan term from June 25, 2025, to June 24, 2026 [2]. - The total guarantee amount provided by the company for its subsidiaries in 2025 is capped at RMB 50 million, and this specific guarantee falls within that limit [2][4]. - After this guarantee, the company's total guarantee balance for Changhe Wind Power is RMB 9.0304 million, leaving a usable guarantee amount of RMB 40.9696 million [2]. Financial Situation of the Subsidiary - As of the end of March 2025, Changhe Wind Power's total assets were RMB 44.50832 million, with total liabilities of RMB 39.19745 million, resulting in a net asset value of RMB 5.31087 million [3]. - The asset-liability ratio for Changhe Wind Power was reported at 88.07% [3]. - The subsidiary's revenue for the first quarter of 2025 was RMB 0.8008 million, with a net loss of RMB 0.9724 million [3]. Contractual Obligations - The guarantee is a joint liability guarantee, meaning that if the subsidiary fails to meet its obligations, the company is liable for the debt without requiring other guarantees to be fulfilled first [4][5]. - The guarantee period extends three years beyond the maturity of each loan [5]. Board's Opinion - The board believes that providing this guarantee is essential for the operational needs of Changhe Wind Power and will not adversely affect the company's normal operations or the interests of shareholders, particularly minority shareholders [6]. Cumulative Guarantee Information - As of the announcement date, the total guarantee amount by the company and its subsidiaries is RMB 9.0304 million, which is 0.33% of the company's latest audited net assets [6]. - There are no overdue guarantees or guarantees involved in litigation as of the current date [6].

Core Viewpoint - Multiple listed companies in the Shanghai and Shenzhen stock markets have announced significant updates, including changes in financing, business performance, and strategic decisions, which may impact investor sentiment and market dynamics [1]. Financing and Restructuring - Guanhao Biological has withdrawn its application for refinancing, leading to the termination of the review process by the Shenzhen Stock Exchange [3]. - Jinhongshun has terminated its major asset restructuring plan due to a lack of consensus among parties involved [6]. - Yuyuan Co. plans to issue bonds not exceeding 40 billion yuan to adjust its debt structure and replenish working capital [23]. Business Performance and Uncertainties - Aored has highlighted significant uncertainties in its computing power leasing services due to heavy asset investment and potential market fluctuations [4]. - Guoyao Modern intends to publicly transfer 51% of its subsidiary Guoyao Hason's shares, as the subsidiary has been underperforming with continuous losses since 2021 [5]. - Chengbang Co. reported that its subsidiary, Xinchun Electronics, has a small business scale and faces intense competition in the semiconductor storage industry, with projected revenues of 111 million yuan and a net profit of 933,800 yuan for 2024 [9]. Stock Market Activity - Alloy Investment announced a change in its controlling shareholder to Jiuzhou Hengchang, with stock trading resuming on July 1 [7]. - Changcheng Military Industry reported significant stock price volatility, with a cumulative increase of over 100% in the last 10 trading days, indicating potential irrational market behavior [8]. Earnings Forecasts - Hanyu Pharmaceutical expects a net profit of 142 million to 160 million yuan for the first half of 2025, recovering from a loss in the previous year, driven by international business growth [12]. - Taotao Vehicle anticipates a net profit increase of 70.34% to 97.81% for the same period, reflecting strong sales performance [13]. - Weichai Heavy Machinery projects a net profit increase of 40% to 60%, benefiting from industry policy support and demand growth [15]. Major Contracts and Projects - China Railway has won contracts for overseas construction projects totaling approximately 5.343 billion yuan [17]. - Zhonggong International has signed a 175 million yuan engineering consulting service contract [18]. - Hezhan Energy has entered into a 177 million yuan contract for the sale of steel-concrete towers [19].

辽宁和展能源集团股份有限公司 关于为全资子公司提供担保的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完 整，没有虚假记载、误导性陈述或重大遗漏。 特别提示： 证券代码：000809 证券简称：和展能源 公告编号：2025-029 本次担保为公司对资产负债率超过 70%的全资子公司提供的担保，敬请投资 者关注担保风险。 一、担保情况概述 为满足业务发展需要，辽宁和展能源集团股份有限公司（以下简称"公司"） 二级全资子公司辽宁昌和风电设备有限公司（以下简称"昌和风电"）向上海浦 东发展银行股份有限公司铁岭分行（以下简称"浦发银行"）申请不超过人民币 8,000 万元授信。2025 年 6 月 30 日，公司与浦发银行签署《最高额保证合同》， 公司为昌和风电向浦发银行在 2025 年 6 月 25 日至 2026 年 6 月 24 日期间内办理 各类融资业务以本金余额最高不超过人民币 5,000 万元为限提供连带责任保证 担保，公司对债权发生期间内各单笔借款合同项下分期履行的还款义务承担保证 责任，保证期间为自每笔债权合同债务履行期届满之日起至该单笔合同最后一期 还款期限届满之日后三年。 2025 ...

本次签署的混塔订单预计在 2025 年 10 月至 2026 年 12 月期间进行交付，将 对 2025 年和 2026 年的财务状况和经营成果产生积极影响，将有效支撑公司业绩 目标。 在合同履约期间，采购方可能依据业主的需要对合同工作内容、供货数量、 设备价格、交货时间进行相应的调整，双方将根据情况协商完成合同工作内容的 1 证券代码：000809 证券简称：和展能源 公告编号：2025-030 辽宁和展能源集团股份有限公司 关于全资子公司签订钢混塔架销售合同的自愿性信息披露公告 本公司及董事会全体成员保证信息披露的内容真实、 准确、完整，没有虚假记载、误导性陈述或重大遗漏。 2025 年 6 月 27 日，辽宁和展能源集团股份有限公司（以下简称"公司"） 二级全资子公司辽宁昌和风电设备有限公司（以下简称"昌和公司"）作为供货 方与采购方北京普华阳光投资有限公司签订《牡丹江林口 300MW 风力发电项目钢 混塔架采购合同》。合同标的物为 54 套 160m 钢混塔架，合同总价款为 17,712 万元（含税）。 按照上述风力发电项目的并网时间及采购方对钢混塔架的预计需求时间，根 据工程进度要求，昌和公司依据自 ...

Core Viewpoint - The company has signed a procurement contract for wind power equipment, which is expected to positively impact its financial performance in 2025 and 2026 [1] Group 1: Contract Details - The company’s wholly-owned subsidiary, Liaoning Changhe Wind Power Equipment Co., Ltd., has entered into a contract with Beijing Puhua Yangguang Investment Co., Ltd. for the procurement of steel-concrete towers for the Mudanjiang Linkou 300MW wind power project [1] - The contract involves the supply of 54 sets of 160m steel-concrete towers, with a total contract value of 177 million yuan (including tax) [1] - The company plans to complete material preparation and start production by August 2025, with a target to finish 30 sets of production by November 2025 [1] Group 2: Delivery and Financial Impact - The order is expected to be delivered between October 2025 and December 2026 [1] - This contract is anticipated to have a positive effect on the company's financial status and operational results for the years 2025 and 2026 [1]

Core Insights - The article discusses the current trends and dynamics in the liquor industry, focusing on the rise of craft beer, the competition among major liquor brands in Hong Kong, and the strategies employed by companies during the off-season to engage consumers [1]. Industry Environment - The craft beer market is experiencing significant growth, driven by instant retail, with some retailers reporting sales increases of 20%-35%. However, traditional liquor distributors remain cautious due to short shelf life and supply chain challenges [2]. - The light bottle liquor market is projected to reach 150 billion by 2024, with potential to exceed 200 billion in the next decade. The "Bashi" brand from Sichuan Chunquan Group is gaining traction in Jiangsu, targeting the 30-60 yuan price range [3]. - Major Chinese liquor brands are rapidly expanding into the Hong Kong market, leveraging tax reductions and differentiated strategies to attract mid-to-high-end consumers, despite facing competition from foreign spirits [5]. - The liquor industry is shifting focus from channel-driven strategies to consumer-driven approaches, with companies like Moutai and Xijiu enhancing brand engagement through immersive experiences [6]. Future Predictions - The liquor industry is expected to undergo three major changes in the next decade: a shift towards smoother flavors to appeal to younger consumers, increased concentration among leading brands, and accelerated integration across different liquor categories [7]. Brand Dynamics - Yanjing Beer has successfully transitioned from single-point marketing to a comprehensive ecosystem approach, significantly increasing its revenue and profitability through high-end product offerings [11][12]. - Kuaizi Jiu is establishing a cultural benchmark with the opening of the largest brewing heritage exhibition hall in China, enhancing its brand's historical significance and supporting its high-end strategy [13]. - The "Shancheng Beer" trademark dispute highlights the challenges foreign brands face in local markets, with Carlsberg's strategy facing scrutiny due to declining brand value [14]. - Wuliangye's "He Mei" wedding event exemplifies the integration of traditional culture and modern marketing, promoting brand engagement through experiential marketing [15]. - China Resources Beer’s dual empowerment strategy for beer and liquor is underperforming, with its liquor segment failing to meet growth targets [17]. - Yanjing Beer is struggling with high-end positioning amidst a competitive landscape, facing challenges in revenue growth and market strategy [18]. - Guojiao 1573 is innovating through cultural narratives, collaborating with intangible cultural heritage artisans to enhance brand identity and consumer connection [19]. - Shacheng Laojiao has achieved remarkable growth, with projected revenue of 1.4 billion in 2024, driven by strategic market focus and product offerings [20]. - Water Well Square is promoting cultural values through its collaboration with artist Zhu Bingren, enhancing brand visibility during the Dragon Boat Festival [21]. - Liu Ling Zui Jiu is leveraging cultural heritage to establish a strong market presence, focusing on product diversity and consumer experience [23]. - Hongxing Erguotou has been recognized as a leading consumer brand in Beijing, emphasizing quality and cultural heritage in its production processes [24].